BIOGEN INC. Research And Development Expense

Quick Answer

BIOGEN INC. reported Research And Development Expense of $1.33 billion for the year ending 2012.

  • BIOGEN INC. showed an increase of +9.5% in Research And Development Expense from 2011 to 2012.
  • This data is from BIOGEN INC.'s annual report (Form 10-K), filed with the SEC on February 5, 2013.
  • XBRL data for this metric is available from 2007 to 2012 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 6 years of available data (2007 to 2012), BIOGEN INC.'s Research And Development Expense has grown by 44.3%.
  • Historical annual values: Fiscal year 2012: $1.33 billion | Fiscal year 2011: $1.22 billion | Fiscal year 2010: $1.25 billion | Fiscal year 2009: $1.28 billion | Fiscal year 2008: $1.07 billion | Fiscal year 2007: $925.16 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: